Clinical Trials (PDQ®)
|Phase IV||Supportive care||Active||16 to 80||Other||idr-3d-001|
Hepatic candidiasis is a frequent complication in patients receiving intensive chemotherapy for acute leukemia. Hepatic lesions may be detected by computerized tomographic (CT) scans, but there is no standardized CT protocol for the diagnosis and follow-up of hepatic candidiasis.
The investigators compared the size of the fungal lesions in the chest and abdomen CT. The current analysis aimed to increase the value of CT for the diagnosis and the follow-up of hepatic candidiasis in daily routine.
- Chest and Abdomen CT with fungal lesion in patients with leukemia
- Other liver pathologies
Trial Lead Organizations/Sponsors
|01 Studienregister MasterAdmins||Study Director|
|01 Studienregister MasterAdmins||Ph: +41 (0)44 255 11 11|
|Thomas Frauenfelder, MD||Principal Investigator|
Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01207843
ClinicalTrials.gov processed this data on October 17, 2013
Back to Top